Cardiac surgery/transplantation, Cardiology/interventional, FDA, Medical Devices | apples49 | 
August 16, 2015 11:19 am
1 Comment
Other Links to this Post
Notice: comments_rss_link is deprecated since version 2.5! Use post_comments_feed_link() instead. in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3406
RSS feed for comments on this post.
By Sarah Huoh, May 19, 2015 @ 1:01 pm
Hi Steven – I’m sending along a copy of Edwards’ press release about the FORTIS transcatheter mitral program for reference, which announces a pause in enrollment. From the release: “We remain committed to and are encouraged by the early experience in transcatheter mitral valve replacement therapy.”
Best,
Sarah
Edwards’ Lifesciences